Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: The DREAMseq Trial – ECOG-ACRIN EA6134
Authors: Truong, Thach-Giao | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | September 27, 2022 | PubMed abstract
